The EPIC-B trial demonstrates the efficacy of cemiplimab monotherapy as a treatment for locally advanced or metastatic penile cancer (la/mPC). The trial met its primary endpoint, with a clinical ...
Q3 2025 Earnings Call Transcript February 13, 2025 Operator: And good day. Thank you for standing by. Welcome to VistaGen ...
Schrödinger faces financial losses amid investment in experimental drugs. Key 2025 trial results will reveal its future ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback